News
We recently published a list of the 15 Low Profile Dividend Champions to Buy. In this article, we are going to take a look at ...
Q1 2025 Earnings Call Transcript April 17, 2025 Badger Meter, Inc. beats earnings expectations. Reported EPS is $1.3, ...
Elinzanetant significantly reduced the frequency and severity of vasomotor symptoms, known as hot flashes, compared with ...
A mum was left shocked and upset after her five-year-old daughter came home from school with a letter describing her as ...
Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight ...
Badger Meter stock (NYSE: BMI) is the top North American provider of water management solutions, offering flow measurement, ...
Benson Boone is set to receive the champion award at the BMI Pop Awards on May 13 at Beverly Wilshire in Beverly Hills.
The results of President Trump’s annual physical exam described a man in “excellent health.” ...
Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.
According to its April STEO, the EIA now sees the Brent spot price averaging $67.87 per barrel in 2025 and $61.48 per barrel in 2026. In its previous STEO, which was released in March, the EIA ...
Rhythm's Phase 3 trial shows setmelanotide significantly reduced BMI in rare hypothalamic obesity without new safety concerns over 52 weeks.
A group of children and adults with hypothalamic obesity receiving setmelanotide for 1 year had nearly a 20% greater BMI reduction than those receiving placebo, according to top-line results released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results